Course5i
Gunjan Kapoor Kochar is a Senior Consultant at Course5i, specializing in oncology and immunology projects, providing strategic insights through competitive analysis and market assessment while managing a team. Previously, Gunjan served as a Deputy Manager at WNS, overseeing a range of oncology projects and collaborating with cross-functional teams to deliver actionable insights to pharma clients. Gunjan's experience includes roles as a Senior Business Analyst and Business Analyst at Evalueserve, focusing on competitive intelligence and market assessment across various therapeutic areas. Gunjan started the professional journey as a Business Coordinator at AKUMS DRUGS & PHARMACEUTICALS LTD, developing new business opportunities. Educational qualifications include a master's degree in pharmaceutical sciences from Pt. B D Sharma College of Pharmacy and a bachelor's degree in pharmaceutical sciences from the University Institute of Pharmaceutical Sciences, Kurukshetra University.
This person is not in the org chart
This person is not in any offices
Course5i
3 followers
Course5 Intelligence Limited (“Course5”) focuses on helping organizations drive digital transformation using artificial intelligence (“AI”), advanced analytics, and insights. Course5’s AI-driven products and solutions and IP-led solutions are supported by industry-specific domain experience and the latest technologies and aim at enablingorganizations to solve complex issues relating to their customers, markets, and supply chain at speed and scale. Course5 combines a multi-disciplinary approach to data integration across structured and unstructured data sources to help businesses grow through informed decision-making. Course5 caters to some of the world’s largest enterprises, including many Fortune 500 companies. The company’s clients span Technology, Media and Telecom (TMT), Pharma & Lifesciences, CPG, Retail, and other sectors. Course5 Intelligence has been recognized by leading industry analysts like Gartner and Forrester for its Analytics and AI capabilities and proprietary AI-based platforms.